US 11673930
IL10 agonists and methods of use thereof
granted A61KA61K38/00A61K38/2066
Quick answer
US patent 11673930 (IL10 agonists and methods of use thereof) held by REGENERON PHARMACEUTICALS, INC. expires Mon Jun 08 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Jun 13 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 08 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61K, A61K38/00, A61K38/2066, A61K47/68, A61K47/6889